DexCom, Inc. - Events & Presentations

IR Contacts

Sean Christensen

Vice President, Finance and Investor Relations

Matt Carey

Senior Investor Relations Manager

(858) 200-0200
investor-relations@dexcom.com

1. JAMA. 2017;317(4):371-378.
2. Welsh, J.B. et al (2019). "Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems." Diabetes Technol Ther 21(3) Dexcom, Dexcom G6, Dexcom Share, and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

*If your glucose alerts and readings from the G6 or G7 CGM Systems do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions.

Powered By Q4 Inc. 5.153.0.3

Events & Presentations

Upcoming Events

Featured Presentation

Archived Events & Presentations

IR Contacts